Yachao Zhang, MD
Vascular & Interventional Radiology · Syracuse, NYNPI 1689932071
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.9%), food and beverage and grants — rather than concentrated in one kind of arrangement. Biocompatibles, Inc. accounts for 60.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $3,025 and has fallen 89.1% since, to $328 in 2025.
Across 27 payments — averaging $133.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biocompatibles, Inc.$2K
- Cook Medical LLC$605
- Boston Scientific$240
- Penumbra, Inc.$230
- Argon Medical Devices, Inc.$153
- Stryker$119
- plus $85 from 1 others
What the payments were for
- Grants$3139%
- Travel & lodging$1,68447%
- Food & beverage$1,59744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biocompatibles, Inc. | 4 | $2,162 |
| Cook Medical LLC | 5 | $605 |
| Boston Scientific | 6 | $240 |
| Penumbra, Inc. | 3 | $230 |
| Argon Medical Devices, Inc. | 3 | $153 |
| Stryker | 5 | $119 |
| Imactis Inc | 1 | $85 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THERASPHERE-BIO$2,162
- Cook Medical Liver Access$199
- OPTION$117
- Indigo System$107
How this compares
$3,594 in reported general payments places this provider in the 60th percentile of 306 vascular & interventional radiology providers in New York.
See all vascular & interventional radiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $8,857 |
| Procto-Med HcHydrocortisone | 68 | $402 |
| Tamsulosin Hcl | 18 | $126 |
| Hydrocortisone | 12 | $95 |
| Ibuprofen | 15 | $73 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Syracuse
- Abhijit SalaskarSyracuse$14K
- Edward KimNew York$831K
- Gary SiskinAlbany$584K
- Robert LooksteinNew York$515K
- Craig GrebenManhasset$456K
- Anuj MalhotraAlbany$288K
- Rahul PatelNew York$275K
- Aaron FischmanNew York$240K
- Philip MeyersNew York$238K
- Abigail FalkNew York$214K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.